Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
0.7794
+0.0289 (3.85%)
At close: Oct 30, 2025, 4:00 PM EDT
0.7564
-0.0230 (-2.95%)
Pre-market: Oct 31, 2025, 4:11 AM EDT
Adicet Bio Stock Forecast
Stock Price Forecast
The 2 analysts that cover Adicet Bio stock have a consensus rating of "Buy" and an average price target of $6.00, which forecasts a 669.82% increase in the stock price over the next year. The lowest target is $4.00 and the highest is $8.00.
Price Target: $6.00 (+669.82%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Adicet Bio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 5 | 3 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 8 | 8 | 6 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +926.43% | Oct 8, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +798.13% | Sep 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +413.22% | Jul 23, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +798.13% | Mar 21, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 7, 2025 |
Financial Forecast
Revenue This Year
2.91M
Revenue Next Year
2.91M
from 2.91M
EPS This Year
-1.13
from -1.33
EPS Next Year
-0.87
from -1.13
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 21.0M | 21.0M | |||
| Avg | 2.9M | 2.9M | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 620.7% | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.00 | -0.57 | |||
| Avg | -1.13 | -0.87 | |||
| Low | -1.23 | -1.08 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.